Pfizer’s coronavirus vaccine is more than 90 percent effective in first analysis, company reports - The Washington Post
Vaccine development typically takes many years, even decades. But the coronavirus vaccines have been a rare success story in the response to the virus, able to move forward because of a flourishing of new vaccine technologies, a backbone of prior work on emerging pathogens and a mentality that rarely exists in the world of vaccine development — of governments and companies willing to devote nearly unlimited resources to make sure that a vaccine succeeds.
While early days, this is encouraging. Isn’t it amazing what science can achieve.
Imagine if the world started trusting science to deal with other issues, like climate change, for instance?